Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
OIG Compares ASP To AMP One More Time
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all
Neuroendocrine tumors Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors
International Journal of Colorectal Disease, 07/10/08
Print     Email This Article     Save in My Library   Free Abstract
Tsukamoto S et al. - In a study to examine the clinicopathological characteristics and prognosis of pts with rectal well-differentiated neuroendocrine tumors (W/D NETs) to clarify the oncological outcome, it was shown that because the incidence of lymph node metastasis is very high in pts with rectal W/D NETs greater than 10 mm in diameter, radical surgery is required. The outcome of rectal W/D NETs pts with lateral pelvic lymph node metastasis was better than expected

Methods
  • 23 pts who underwent surgical treatment with lymph node dissection for rectal W/D NETs were reviewed

Results
  • Median tumor size measured preoperatively was 13 mm, and the median number of dissected lymph nodes was 16
  • The incidence of lymph node metastasis was 61%
  • The smallest W/D NETs with lymph node metastasis was 10 mm in diameter
  • All pts without lymph node metastasis survived without recurrence
  • Among 11 pts who had only regional lymph node metastasis, only 1 developed liver metastasis and died 13 months after initial surgery
  • Among 3 pts with lateral pelvic lymph node metastasis, 2 survived more than 5 years, although 2 had liver metastasis

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.